MIRA INFORM REPORT

 

 

Report Date :

17.05.2012

 

IDENTIFICATION DETAILS

 

Name :

SUDEEP PHARMA LIMITED

 

 

Registered Office :

129/ 1/A, G.I.D.C. Estate, Nandesari, Baroda – 391340, Gujarat

 

 

Country :

India

 

 

Financials (as on) :

31.03.2011

 

 

Date of Incorporation :

21.12.1989

 

 

Com. Reg. No.:

04-013141

 

 

Capital Investment / Paid-up Capital :

Rs. 12.681 millions

 

 

CIN No.:

[Company Identification No.]

U24231GJ1989PLC013141

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

BRDS02074C

 

 

PAN No.:

[Permanent Account No.]

AACCS9716J

 

 

Legal Form :

A Closely Held Public Limited Liability Company.

 

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical, Food and Feed Ingredients.

 

 

No. of Employees :

150 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (46)

 

RATING

STATUS

PROPOSED CREDIT LINE

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

 

Maximum Credit Limit :

USD 200000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually Correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track. Trade relations are reported as fair. Business is active. Payments are reported to be usually correct and as per commitments.

 

The company can be considered normal for business dealings at usual trade terms and conditions.

 

 

NOTES:

 

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

INFORMATION PARTED BY

 

Name :

Mrs. Bhatt

Designation :

Account Manager

Contact No.:

91-22-25185766

Date :

16.05.2012

 

 

LOCATIONS

 

Registered Office / Factory:

129/ 1/A, G.I.D.C. Estate, Nandesari, Baroda – 391340, Gujarat, India

Tel. No.:

91-265-2840656 / 3291354

Fax No.:

91-265-2841250 / 2336284

E-Mail :

mail@sudeepgroup.com

Website :

http://www.sudeepgroup.com

Area :

10000 sq. ft.

Location :

Owned

 

 

Branch Office :

D/307 Kailash Complex, Vikhroli Park Site, Vikhroli (West), Mumbai, Maharashtra, India

Tel. No.:

91-22-25185766 / 67254281

Fax No. :

91-22-25185766

E-Mail :

sudeepbo@vsnl.com

Area :

600 Sq. Ft.

Location :

Owned

 

 

DIRECTORS

 

As on 31.03.2011

 

Name :

Mr. Jaysukh .J. Bhayani

Designation :

Managing Director

Address :

66, Kunj Society, Alkapuri, Vadodara – 390 005, Gujarat, India

Date of Birth/Age :

23.07.1941

Date of Appointment :

21.10.1992

DIN No.:

01551347

 

 

Name :

Mr. Sujit .J. Bhayani

Designation :

Whole Time Director

Address :

66, Kunj Society, Alkapuri, Vadodara – 390 005, Gujarat, India

Date of Birth/Age :

28.06.1967

Date of Appointment :

01.03.1995

DIN No.:

01767427

 

 

Name :

Mr. Rajendra .C. Patel

Designation :

Director

Address :

303 Ramkrishna Flats Alkapuri, Vadodara - 390005, Gujarat, India

Date of Birth/Age :

12.09.1945

Date of Appointment :

01.02.2009

DIN No.:

02541744

 

 

Name :

Mr. Vishal Rakesh Agrawal

Designation :

Director

Address :

61, Alkapur Society, Alkapuri, Vadodar - 390005, Gujara, India

Date of Birth/Age :

01.10.1974

Date of Appointment :

01.04.2011

DIN No.:

00056800

 

 

KEY EXECUTIVES

 

Name :

Mrs. Bhatt

Designation :

Account Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

AS ON 27.09.2010

 

Names of Shareholders

 

No. of Shares

Jaysukh J. Bhayani

 

147780

Sujit Bhayani

 

147600

J. J. Bhayani – H.U.F.

 

112500

Avani S. Bhayani

 

                180000

Sujit Bhayani H.U.F.

 

231250

Anjana R. Patel

Shanil S Bhayani

 

84000

Sujit J. Bhayani

Avani S. Bhayani

 

286250

Avani S. Bhayani

Sujit J. Bhayani

 

54720

Rajendra C. Patel

Shanil S. Bhayani

 

20000

Shanil S. Bhayani

Sujit J. Bhayani

 

2000

Rhea S. Bhayani

Sujit J. Bhayani

 

2000

Total

 

1268100

 

 

AS ON 27.09.2010

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Percentage

Directors or relatives of directors

 

100.00

Total

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Exporter of Pharmaceutical, Food and Feed Ingredients.

 

 

Products :

Item Code No. (ITC Code)

Product Description

2835

Dicalcium Phosphate/ TCP/ MM Etc. Pharma Intermediates

 

  • Di Basic Calcium Phosphate Dihydrate (Milled)
  • Di Basic Calcium Phosphate Dihydrate (Directly Compressible)
  • Di Basic Calcium Phosphate Anhydrous (Milled)
  • Di Basic Calcium Phosphate Anhydrous (Directly Compressible)
  • Di Calcium Phosphate (Animal Feed Grade)
  • Mineral/Vitamin Mixtures for Cattle/Poultry feeds
  • Carbamazepine BP/USP
  • Tri Calcium Phosphate

 

 

Exports :

 

Products :

Pharmaceutical, Food and feed Ingredients

Countries :

  • USA
  • UK
  • Australia
  • German
  • Netherlands
  • China
  • Taiwan
  • Italy
  • Switzerland
  • Canada

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit

 

 

PRODUCTION STATUS (As on 31.03.2011)

 

Particulars

Unit

Licensed Capacity

Installed Capacity

 

 

 

 

DCP /TCP /MM etc. (Pharma Products)

Kgs

NA

6000000

 

 

 

 

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers and Retailers

 

 

No. of Employees :

150 (Approximately)

 

 

Bankers :

·         Bank of Baroda, Nandesari Industrial Branch, Nandesari, District Baroda, Vadodara – 391340, Gujarat, India

·         ICICI Bank, India

·         HDFC Bank, India

 

 

Facilities :

Secured Loans

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

A] From Bank

 

 

Term Loan

(Secured by equitable mortgage of Land and Building and hypo of Immovable Plant and Machinery)

9.764

5.663

Working Capital facilities

 

 

Cash Credit

27.038

13.373

Packing Credit

(Secured against hypo of Inventories and Book debts)

5.871

10.100

Vehicle Loan

(Secured against hypo of Car)

3.727

0.517

B] From ICICI and HDFC

 

 

Vehicles Loan

(Secured against hypo of Car)

0.000

0.101

Total

46.400

30.654

 

 

Unsecured Loans

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

From Directors

0.153

0.165

From Shareholders

5.780

2.651

From Others

0.000

0.215

Total

5.933

3.031

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Shah Mehta and Bakshi

Chartered Accountants

Address :

2nd Floor, Prasanna House, Associated Opposite Radhakrishna, Near Akota Stadium, Vadodara – 390 020, Gujarat, India

Tel No. :

91-265-2331060/ 2337727/ 2355435

Fax No. :

91-265-2654630/ 2343227

Pan No.:

AAUPM0018Q

Email :

itr@smb-ca.com

office@smo-ou.com

 

 

CAPITAL STRUCTURE

 

As on 31.03.2011

 

Authorised Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

6000000

Equity Shares

Rs. 10/- each

Rs. 60.000 millions

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

 

No. of Shares

Type

Value

Amount

 

 

 

 

1268100

Equity Shares

Rs. 10/- each

Rs. 12.681 millions

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2011

31.03.2010

31.03.2009

 

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

12.681

12.681

12.681

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

61.543

36.162

32.560

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

74.224

48.843

45.241

LOAN FUNDS

 

 

 

1] Secured Loans

46.400

30.654

35.427

2] Unsecured Loans

5.933

3.031

1.348

TOTAL BORROWING

52.333

33.685

36.775

DEFERRED TAX LIABILITIES

3.624

3.227

3.033

 

 

 

 

TOTAL

130.181

85.755

85.049

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

69.375

61.835

51.364

Capital work-in-progress

7.039

0.024

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERREX TAX ASSETS

0.000

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

27.433
14.203
16.400

 

Sundry Debtors

46.782
32.214
31.575

 

Cash & Bank Balances

1.358
0.110
0.057

 

Other Current Assets

18.611
8.181
10.438

 

Loans & Advances

0.000
0.000
0.000

Total Current Assets

94.184

54.708

58.470

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditor

21.862
15.960
17.063

 

Other Current Liabilities

1.919
2.298
2.008

 

Provisions

16.984
13.251
6.759

Total Current Liabilities

40.765
31.509
25.830

Net Current Assets

53.419
23.199
32.640

 

 

 

 

MISCELLANEOUS EXPENSES

0.348

0.697

1.045

 

 

 

 

TOTAL

130.181

85.755

85.049

 

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2011

31.03.2010

31.03.2009

 

 

SALES

 

 

 

 

 

Income

293.417

223.560

237.459

 

 

Other Income

1.552

0.812

0.049

 

 

TOTAL                                     (A)

294.969

224.372

237.508

 

 

 

 

 

Less

EXPENSES

 

 

 

 

Increase/ (Decrease) in Stock

(12.490)

6.418

 

 

 

Manufacturing Expenses

207.794

140.923

198.860

 

 

Admin and Selling Expenses 

37.234

29.149

 

 

 

TOTAL                                     (B)

232.538

176.490

198.860

 

 

 

 

 

Less

PROFIT BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)      (C)

62.431

47.882

38.648

 

 

 

 

 

Less

FINANCIAL EXPENSES                         (D)

5.684

3.424

4.057

 

 

 

 

 

 

PROFIT BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                       (E)

56.747

44.458

34.591

 

 

 

 

 

Less/ Add

DEPRECIATION/ AMORTISATION                     (F)

5.259

4.633

3.852

 

 

 

 

 

 

PROFIT BEFORE TAX (E-F)                               (G)

51.488

39.825

30.739

 

 

 

 

 

Less

TAX                                                                  (H)

18.517

14.339

11.744

 

 

 

 

 

 

PROFIT AFTER TAX (G-H)                                (I)

32.971

25.486

18.995

 

 

 

 

 

Less

Prior Period Adjustment

0.220

0.035

0.058

 

 

 

 

 

Add

Depreciation Earlier years w/back

0.000

0.405

0.556

 

 

 

 

 

Add

PREVIOUS YEARS’ BALANCE BROUGHT FORWARD

30.613

29.597

10.104

 

 

 

 

 

Less

APPROPRIATIONS

 

 

 

 

 

Transfer to General Reserve

3.275

2.586

0.000

 

 

Dividend

6.340

19.022

0.000

 

 

Tax on Dividend

1.029

3.233

0.000

 

BALANCE CARRIED TO THE B/S

52.720

30.613

29.597

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Export Earnings

139.240

124.901

140.104

 

TOTAL EARNINGS

139.240

124.901

140.104

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Raw Materials

92.047

41.858

26.480

 

TOTAL IMPORTS

92.047

41.858

26.480

 

 

 

 

 

 

Earnings Per Share (Rs.)

26.00

20.10

14.98

 

 

Particulars

 

 

 

31.03.2012

Sales Turnover (Approximately)

 

 

330.000

 

Expected Sales (2012-2013) : Rs. 370.000 Millions

 

The above information has been parted by Mrs. Bhatt.

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2011

31.03.2010

31.03.2009

 

PAT / Total Income

(%)

11.18

11.36

7.99

 

 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

17.55
17.81
12.94

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

31.48

34.17

27.99

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.69

0.82

0.68

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

1.30

1.33

1.38

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

2.31

1.74

2.26

 

 

LOCAL AGENCY FURTHER INFORMATION

 

SUNDRY CREDITORS DETAILS:

 

Particulars

Rs. In Millions

31.03.2011

Rs. In Millions

31.03.2010

Rs. In Millions

31.03.2009

Creditors – Raw Materials

11.444

6.382

9.282

Creditors –  Others

10.418

9.578

7.781

Total

21.862
15.960
17.063

 

 

Check list by info Agents

Available in Report (Yes/ No)

Year of Establishment

Yes

Locality of the Firm

Yes

Constitution of the Firm

Yes

Premises details

Yes

Type of Business

Yes

Line of Business 

Yes

Promoter’s Background 

Yes

No. of Employees

Yes

Name of Person Contacted

Yes

Designation of Contact person

Yes

Turnover of Firm for last three years

Yes

Profitability for last three years

Yes

Reasons for variation <> 20%

-------------

Estimation for coming financial year

Yes

Capital in the business

Yes

Details of sister concerns

No

Major Suppliers

No

Major Customers

No

Payments Terms

Yes

Export/ Imports Details (If applicable)

Yes

Market Information

-------------

Litigations that the firm/ Promoters Involved in

--------------

Banking details

Yes

Banking Facility Details

Yes

Conduct of the Banking Account

-----------

Buyer visit details

-----------

Financials, if provided

Yes

Incorporation details is applicable

Yes

Last Accounts filed at ROC

Yes

Major Shareholders, if available

Yes

 

 

Note:

 

The registered office of the company has been shifted from 66, Kunj Society, Alkapuri, Vadodara – 390 005, Gujarat, India to the present address w.e.f. 14.03.2009.

 

 

Bank Charges:

 

Corporate identity number of the company

U24231GJ1989PLC013141

Name of the company

SUDEEP PHARMA LIMITED

Address of the registered office or of the principal place of  business in India of the company

129/ 1/ A, G.I.D.C. Estate, Nandesari, Baroda – 391340, Gujarat, India

This form is for

Modification of charge

 

90103900

Type of charge

Immovable Property

Particular of charge holder

Bank of Baroda, Nandesari Branch, GIDC Estate Nandesari, Baroda – 391340, Gujarat, India

E-Mail: indnan@bankofbaroda.com

Nature of instrument creating charge

Instrument of Extension / Creation of Mortgage Relating to Constructive / Actual Deposit of Title Deeds

Date of instrument Creating the charge

27.09.2011

Amount secured by the charge

Rs. 99.571 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of Interest

As Per Agreement

 

Terms of Repayment

As Per Agreement

 

Margin

As Per Agreement

 

Extent and Operation of the charge

As Per Agreement

Short particulars of the property charged

Leasing Immovable Property Being Plot No. 129/1/A Admeasuring 3024 Sq. Mtrs or thereabout in Nandesari Industrial Estate, Situated on Land Bearing Revenue Survey No. 528,525 and 520 Within The Village

 

Limits of Nandesari, Registration Sub District and District Baroda and Bounded on or towards

 

Leasehold Immovable Property Being Plot/Shed no C-1/B/129/12 In Nandesari Industrial Area Situate on Land Bearing Revenue Survey No 530/Part, Admeasuring 608 Sq Mtrs Within The Village Limits of

 

Nandesari, Registration Sub District and District Baroda and Bounded on or towards

 

Leasehold Immovable Property Being Plot/Shed no C-1/B/129/13 In Nandesari Industrial Area Situate on Land Bearing Revenue Survey No 530/Part, Admeasuring 608 Sq Mtrs Within The Village Limits of

 

Nandesari, Registration Sub District and District Baroda and Bounded on or towards

 

Leasehold Immovable Property Being Plot/Shed no C-1/B/129/14 In Nandesari Industrial Area Situate on Land Bearing Revenue Survey No 514/P, 515/P Admeasuring 749.88 Sq Mtrs Within The Village Limits of

 

Nandesari, Registration Sub District and District Baroda and Bounded on or towards

 

Leasehold Immovable Property Being Plot Known As 129/15 and 126/2 In Nandesari Industrial Area of GIDC Situate on Land Bearing Revenue Survey No 514/P And 530/P Within The Village Limits of Nandesari

 

Registration Sub District and District Baroda and Bounded on or towards

Date of latest modification prior to the present modification

07.07.2011

Particulars of the present modification 

By this document the charge stands extended to Rs. 99.571 Millions from Rs. 81.417 Millions.

 

 

FIXED ASSETS:

 

  • Land Leasehold
  • Office
  • Factory Shed
  • Plant and Machinery
  • Pipes, Valves and Structures
  • Electrification
  • Laboratory Equipments
  • Computer
  • Vehicles
  • Office Equipments
  • Misc fixed assets
  • Furniture and Fixtures

 

 

AS PER WEB DETAILS

 

PROFILE

 

Subject established in 1989 for the production of Pharmaceutical, Food and Feed ingredients. Their major products are various kinds of Calcium Phosphates, with annual capacities 10,000 MT. They are the largest manufacturer and exporter catering to the requirements of over 600 content customers around the globe. Their regular exports are to USA, UK, Canada, Australia, Netherlands, Germany, Portugal, Switzerland, Italy, Indonesia, Taiwan, Thailand and South Africa.

 

All products are manufactured under standards of good manufacturing practice (GMP) & comply with various international official compendia such as The United States Pharmacopeia / National Formulary (USP/NF), The European Pharmacopeia (EP) & the British Pharmacopeia (BP)

 

Quality is one of the most important aspects in our corporate philosophy. We have a strict procedure in place to ensure consistent production and quality. It all begins with raw material testing, procured from approved suppliers leading to the stages of production and ends with timely dispatches.

 

Their highly trained and motivated employees are an integral link of the production chain. Their professionalism and high standards in all departments has resulted in a world wide acceptance of our products.

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 54.29

UK Pound

1

Rs. 86.60

Euro

1

Rs. 68.87

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Report Prepared by :

ACH


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

6

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILIRY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

----

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

46

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

 

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.